In contrast, patients who achieved complete or partial remission after rituximab treatment had higher baseline serum albumin levels (3.6 – SD 1.0 vs 2.8 – SD 0.9), no diagnosis of hypertension (12.5%), and were steroid-sensitive (100%). The gene discussed is ALB; the disease is hypertensive disorder.